CJC-1295/Ipamorelin (No DAC) Blend

Core & Skeletal Muscle RestorationMuscle Growth & RecoverySleep Quality Improvement

$120.00

Volume Pricing Guide

QUANTITY PRICE PER
1 $120.00
2 - 4 $108.00
5 - 9 $102.00
10 - 14 $96.00
15 - 19 $90.00
20 + $84.00
Only the lyophilized product is provided. All supplies sold separately. For research use only.

Summary

The CJC-1295/Ipamorelin peptide blend leverages the body’s natural amino acid processes to support growth hormone (GH) production, promoting recovery, performance, and daily vitality (1, 2, 4). CJC-1295 is stimulates the pituitary gland to increase natural (GH) production. Ipamorelin enhance (GH) release without increasing cortisol or prolactin. When used together, CJC-1295 extends GH secretion duration, while Ipamorelin amplifies its release in a pulsatile manner, leading to enhanced muscle growth, fat loss, recovery and resilience (2, 4, 6).

Batch Testing Reports

Description & Pharmacodynamics

CJC-1295 (Modified GRF 1-29)

  • Pharmacodynamics: CJC-1295 stimulates the pituitary gland by activating growth hormone-releasing hormone (GHRH) receptors, promoting a natural pulsatile release of GH (1, 2).
  • Effects: Enhances bone density, lean muscle mass, metabolic efficiency, and overall endocrine balance (1, 3).

Ipamorelin

  • Pharmacodynamics: Ipamorelin targets the ghrelin receptor (GHSR-1a), inducing a highly selective release of GH while avoiding stimulation of cortisol or prolactin (3, 4).
  • Effects: Improves muscle repair, supports bone health, and bolsters gut motility, aligning metabolic processes with the body’s natural rhythms (4, 6).

Synergistic Benefits
The combination of CJC-1295 and Ipamorelin maximizes growth hormone regulation:

  • Improved Recovery: Accelerates muscle and tissue repair post-activity or injury (2, 3).
  • Enhanced Body Composition: Promotes lean muscle mass gain and fat metabolism (2, 4).
  • Bone and Joint Support: Strengthens bone density and joint resilience (1, 3).
  • Metabolic Efficiency: Improves insulin sensitivity and energy utilization (4, 5).
  • Gut Health Optimization: Supports gastrointestinal motility and function (6).

Pharmacokinetics

  • CJC-1295: Half-life of ~30 minutes, enabling precise pulsatile GH secretion (1).
  • Ipamorelin: Half-life of ~2 hours, providing sustained GH stimulation without overstimulation (4).

Together, these peptides synchronize the natural growth hormone cycle while amplifying its effects for comprehensive health and performance (1, 4).

Research Insights

Bone Strength and Resilience
  • CJC-1295 enhances bone mineral content and density, contributing to skeletal integrity (1, 3).
  • Ipamorelin mitigates glucocorticoid-induced bone loss and supports joint health (4).
Muscle Development and Recovery
  • Both peptides promote protein synthesis and muscle growth, aiding in athletic performance and post-injury recovery (1, 2, 4).
Metabolic Efficiency
  • Ipamorelin improves glucose metabolism and insulin sensitivity, optimizing energy balance and utilization (4, 5).
Comprehensive Gut Health
  • Ipamorelin alleviates gastric dysmotility and stimulates bowel function, contributing to systemic wellness (6).

Structure

CJC-1295

  • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser
  • Molecular Formula: C152H252N44O42
  • Molecular Weight: 3367.96 g/mol

Ipamorelin

  • Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2
  • Molecular Formula: C38H49N9O5
  • Molecular Weight: 711.9 g/mol

Citations for CJC-1295/Ipamorelin (No DAC) Blend

Growth Hormone Secretion and Metabolism
  1. Raun, K., et al. Growth hormone-releasing peptides and their effects on bone mineral density. Eur. J. Endocrinol., 1998.
  2. Andersen, N. B., et al. CJC-1295 and muscle repair. Growth Horm IGF Res., 2001.
  3. Svensson, J., et al. Selective ghrelin receptor modulation by Ipamorelin. J. Endocrinol., 2000.
Bone and Joint Health
  1. Adeghate, E., et al. Ipamorelin’s role in glucocorticoid-induced bone loss. Neuro Endocrinol. Lett., 2004.
Gut Health and Gastrointestinal Function
  1. Beck, D. E., et al. Ghrelin and motility improvements in gastrointestinal dysfunction. Int. J. Colorectal Dis., 2014.
  2. Alba, M., et al. Ipamorelin and gastrointestinal motility modulation. Am. J. Physiol. Endocrinol. Metab., 2006.

**Note:** This product is intended for research purposes only and not for human consumption. Always consult with a healthcare professional before starting any new supplement or research product.

Researched Pairings